Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

Evolve Medical Education LLC

Current and Emerging Glaucoma Therapy An Update on Disease-Modifying Glaucoma Treatments

Access Activity

Overview / Abstract:

This continuing medical education (CME) and continuing education (CE) activity captures content from a roundtable discussion held in March of 2017.

This certified CME/CE activity is designed for optometrists managing glaucoma patients and glaucoma specialists and general ophthalmologists involved in the management of glaucomatous disorders.
Upon completion of this activity, the participant should be able to:
Discuss the chemical structure and mechanism of action of topical glaucoma medications and evolving neuroprotective medications
Explain the antifibrotic activity in novel drug classes
Evaluate novel therapeutics and classes of drugs and their potential for enhanced patient compliance

Expiration

Jul 07, 2019

Discipline(s)

Optometry / Ophthalmology CE, Physician CME

Format

Monograph

Credits / Hours

1

Accreditation

ACCME, COPE

Presenters / Authors / Faculty

THOMAS SAMUELSON, MD, MODERATOR; JASON BACHARACH, MD; MURRAY FINGERET, OD; L. JAY KATZ, MD

Activity Specialities / Related Topics

Ophthalmology / Optometry

Sponsors / Supporters / Grant Providers

Aerie Pharmaceuticals

Keywords / Search Terms

Evolve Medical Education LLC Free CE CME. Glaucoma, Optometry, Ophthalmology, IOP, ocular therapeutics, ocular medications

Access Activity

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.